Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Randomized Clinical Trials of Letrozole Administration During Luteal Phase in Patients Who Have the Risk of Ovarian Hyperstimulation Syndrome

Next Previous
Trial Profile

The Randomized Clinical Trials of Letrozole Administration During Luteal Phase in Patients Who Have the Risk of Ovarian Hyperstimulation Syndrome

Status: Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Jul 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Letrozole (Primary) ; Dexamethasone; Polygeline; Sodium chloride
  • Indications Ovarian hyperstimulation syndrome
  • Focus Therapeutic Use

Most Recent Events

  • 18 Jul 2023 Planned End Date changed from 1 Mar 2017 to 1 Dec 2024.
  • 18 Jul 2023 Planned primary completion date changed from 1 Dec 2016 to 1 Mar 2024.
  • 18 Jul 2023 Planned initiation date changed from 1 Apr 2016 to 1 Dec 2023.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top